Correlation of Ischemia-Modified Albumin with SOFA and APACHE II Scores in Preoperative Patients with Colorectal Cancer

Table 1

Clinical data of the studied patients.

Variable	Levels
Age, years	69 ± 12
Men : women	15 : 12
IMA, AU	0.53 ± 0.10
CRP, mg/dL	0.6 (0.1–5.5)
SOFA, points	2 (0–3)
APACHE II, points	12 (7–16)
Body temperature, °C	36.6 ± 0.7
Mean blood pressure, mmHg	90 ± 23
Hypotension or use of an inotrope,	6 (22%)
Heart rate, bpm	86 ± 24
Respiratory rate, breaths/min	20 ± 8
A-aDO2 (FiO2 > 50%) or PaO2 (FiO2 < 50%), mmHg	375 ± 121
pH	7.4 ± 0.9
Plasma sodium, mmol/L	139 ± 4
Plasma potassium, mmol/L	4.3 ± 0.8
Serum creatinine, mol/L	80 (53–114)
Acute renal failure,	2 (0.7%)
Hematocrit, %	34.8 ± 6.5
Leukocytes, ×10^9/L	6.7 (4.7–12.3)
Platelets, ×10^9/L	239 ± 86
Bilirubin, mol/L	12 (9–14)
Glasgow coma scale, points	14.4 ± 1.6
Organ insufficiency or immunodeficiency,	13 (48%)

IMA: ischemia-modified albumin; CRP: C-reactive protein; SOFA: sequential organ failure assessment; APACHE: acute physiology and chronic health evaluation.
Data are expressed as means ± standard deviations, medians (interquartile ranges), or patient numbers.